Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Will Segmental Revenues Bolster FTAI Aviation's Q1 Earnings?
Will Segmental Revenues Bolster FTAI Aviation's Q1 Earnings?

FTAI Aviation Ltd. FTAI is slated to report first-quarter 2025 results on April 30, 2025, after market close.FTAI has a four-quarter average negative earnings surprise of 12.17%. The strong top-line

Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline
Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on lower revenues when Y-mAbs Therapeutics, Inc. (YMAB) reports results for the quarter ended March 2025. While this widely-known consensus

VSE (VSEC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
VSE (VSEC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects VSE (VSEC) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Wynn Resorts (WYNN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wynn Resorts (WYNN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wynn Resorts (WYNN) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for

The market expects Entrada Therapeutics, Inc. (TRDA) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Earnings Preview: The ONE Group Hospitality, Inc. (STKS) Q1 Earnings Expected to Decline
Earnings Preview: The ONE Group Hospitality, Inc. (STKS) Q1 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on higher revenues when The ONE Group Hospitality, Inc. (STKS) reports results for the quarter ended March 2025. While this widely-known

Analysts Estimate Varonis Systems (VRNS) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Varonis Systems (VRNS) to Report a Decline in Earnings: What to Look Out for

Varonis Systems (VRNS) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Analysts Estimate Voya Financial (VOYA) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Voya Financial (VOYA) to Report a Decline in Earnings: What to Look Out for

The market expects Voya Financial (VOYA) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Will Latham Group (SWIM) Report Negative Earnings Next Week? What You Should Know
Will Latham Group (SWIM) Report Negative Earnings Next Week? What You Should Know

The market expects Latham Group (SWIM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

SolarEdge Technologies (SEDG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
SolarEdge Technologies (SEDG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

SolarEdge Technologies (SEDG) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Will Rivian Automotive (RIVN) Report Negative Earnings Next Week? What You Should KnowPhoto, wide shot, wide-angle lens, soft focus,  Auto parts supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-XjwbnkgTrFCFx6Y3gLbqZBCj.png?st=2023-05-13T09%3A21%3A52Z&se=2023-05-13T11%3A21%3A52Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T06%3A55%3A39Z&ske=2023-05-14T06%3A55%3A39Z&sks=b&skv=2021-08-06&sig=wJlbn/o%2BieTjclaQNRsJc%2BDDZieC0UCS6BPi5tapxAA%3D
Will Rivian Automotive (RIVN) Report Negative Earnings Next Week? What You Should Know

The market expects Rivian Automotive (RIVN) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth
Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Sarepta Therapeutics (SRPT) reports results for the quarter ended March 2025. While this widely-known consensus

Shoals Technologies Group (SHLS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Shoals Technologies Group (SHLS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Wall Street expects a year-over-year decline in earnings on lower revenues when Shoals Technologies Group (SHLS) reports results for the quarter ended March 2025. While this widely-known consensus

Earnings Preview: Revolve Group (RVLV) Q1 Earnings Expected to Decline
Earnings Preview: Revolve Group (RVLV) Q1 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on higher revenues when Revolve Group (RVLV) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Analysts Estimate Pacira (PCRX) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Pacira (PCRX) to Report a Decline in Earnings: What to Look Out for

Pacira (PCRX) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a

Earnings Preview: Resideo Technologies (REZI) Q1 Earnings Expected to Decline
Earnings Preview: Resideo Technologies (REZI) Q1 Earnings Expected to Decline

The market expects Resideo Technologies (REZI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Qualys (QLYS) Earnings Expected to Grow: Should You Buy?
Qualys (QLYS) Earnings Expected to Grow: Should You Buy?

The market expects Qualys (QLYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Ferrari (RACE) Earnings Expected to Grow: Should You Buy?
Ferrari (RACE) Earnings Expected to Grow: Should You Buy?

The market expects Ferrari (RACE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Premier, Inc. (PINC) Expected to Beat Earnings Estimates: Should You Buy?
Premier, Inc. (PINC) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Premier, Inc. (PINC) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Lemonade (LMND) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Lemonade (LMND) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects Lemonade (LMND) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

LCI (LCII) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
LCI (LCII) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

LCI (LCII) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good

Par Petroleum (PARR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Par Petroleum (PARR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year decline in earnings on lower revenues when Par Petroleum (PARR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Leidos (LDOS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Leidos (LDOS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Leidos (LDOS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Will Lucid Group (LCID) Report Negative Earnings Next Week? What You Should Know
Will Lucid Group (LCID) Report Negative Earnings Next Week? What You Should Know

Wall Street expects a year-over-year increase in earnings on higher revenues when Lucid Group (LCID) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?

Krystal Biotech, Inc. (KRYS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus